Alternative Medicine
Obesity and depression: Doctors find genetic connection – Genetic defect causes obesity and postpartum depression
Two diseases, one cause: Changes in the so-called TRPC5 gene can cause obesity and depression in mothers after birth, as doctors have discovered. Both diseases are therefore caused by neurological disorders in the brain that are caused by this genetic defect. Gene therapy or drug treatments could provide relief in both cases in the future. […]
Insights into neural stem cell research » BRAIN AND PATH » SciLogs
Doctors are regularly confronted with diseases whose cruelty is heartbreaking. Epidermolysis Bullosa is such a disease: the skin of the terminally ill reacts to even the slightest contact and stimuli with blistering and peeling, so that infections, scars and pain become a constant companion. Most of those affected die in childhood and adolescence. This made […]
Börse Express – IRW-News: Defence Therapeutics Inc.: Defence to attend the Society of Nuclear Medicine and Molecular Imaging Annual Meeting in Toronto on June 11, 2024
IRW-PRESS: Defence Therapeutics Inc.: Defence to attend Society of Nuclear Medicine and Molecular Imaging Annual Meeting in Toronto on June 11, 2024 Vancouver, British Columbia, Canada, June 10, 2024 – Defence Therapeutics Inc. (“Defence” or the “Company”) (CSE: DTC, OTCQB: DTCFF, Frankfurt Stock Exchange: DTC), a Canadian biopharmaceutical company developing novel immuno-oncology therapeutics and drug […]
DEFENCE TO PARTICIPATE IN THE ANNUAL MEETING OF THE SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING IN TORONTO ON 11 JUNE 2024
EQS-News: Defence Therapeutics Inc. / Key word(s): Conference DEFENCE TO PARTICIPATE IN THE ANNUAL MEETING OF THE SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING IN TORONTO ON 11 JUNE 2024 10.06.2024 / 16:30 CET/CESTThe issuer is responsible for the content of this announcement. CSE: DTC Frankfurt Stock Exchange: DTC USOTC: DTCFF PRESS RELEASE DEFENCE TO […]
Ozempic reduces the risk of dying from kidney disease
Home page To know Was standing: 03.06.2024, 04:52 PressSplit Ozempic insulin injection pen (symbol image). © Pond5 Images/Imago Ozempic is prescribed to diabetes patients and is also considered a weight loss agent. Now a new study shows that it also helps with kidney disease. The active ingredient in the best-selling drug Ozempic significantly reduces the […]
Ozempic reduces the risk of dying from kidney disease
Home page World Was standing: 03.06.2024, 04:52 PressSplit Ozempic insulin injection pen (symbol image). © Pond5 Images/Imago Ozempic is prescribed to diabetes patients and is also considered a weight loss agent. Now a new study shows that it also helps with kidney disease. The active ingredient in the best-selling drug Ozempic significantly reduces the risk […]
Ozempic reduces the risk of dying from kidney disease
Home page World Was standing: 02.06.2024, 19:15 PressSplit Ozempic insulin injection pen (symbol image). © Pond5 Images/Imago Ozempic is prescribed to diabetes patients and is also considered a weight loss agent. Now a new study shows that it also helps with kidney disease. The active ingredient in the best-selling drug Ozempic significantly reduces the risk […]
Ozempic reduces the risk of dying from kidney disease
Home page To know Was standing: 02.06.2024, 12:43 PressSplit Ozempic insulin injection pen (symbol image). © Pond5 Images/Imago Ozempic is prescribed to diabetes patients and is also considered a weight loss agent. Now a new study shows that it also helps with kidney disease. The active ingredient in the best-selling drug Ozempic significantly reduces the […]
Ozempic reduces the risk of dying from kidney disease
Home page To know Was standing: 01.06.2024, 08:25 a.m. PressSplit Ozempic insulin injection pen (symbol image). © Pond5 Images/Imago Ozempic is prescribed to diabetes patients and is also considered a weight loss agent. Now a new study shows that it also helps with kidney disease. The active ingredient in the best-selling drug Ozempic significantly reduces […]
ONWARD® Medical hosts webcast to discuss details of
Results of the Up-LIFT approval study published in Nature Medicine Discussing the results of the pivotal study in a webcast this week with company executives, study leaders and participants EINDHOVEN, Netherlands, May 22, 2024 (GLOBE NEWSWIRE) — ONWARD Medical NV (Euronext: ONWD), the medical device company developing innovative spinal cord stimulation therapies to restore movement, […]